Skip to main content

Uroonkologie beim älteren Patienten

  • Chapter
  • First Online:
Uroonkologie
  • 2814 Accesses

Zusammenfassung

Mit Ausnahme der Hodentumoren stellen urologische Malignome typische Erkrankungen des höheren Lebensalters dar. Das Spektrum dieser malignen Erkrankungen reicht von sehr langsamen Verläufen ohne klinisch relevante Auswirkungen auf Morbidität oder Mortalität bis zu aggressiven Erkrankungen mit erheblichen Konsequenzen. In der Behandlung älterer/geriatrischer Patienten gilt es, die Konsequenzen einer Therapie gegen den natürlichen Verlauf der Erkrankung unter Berücksichtigung der individuellen Belastbarkeit und Prognose sowie der Patientenpräferenzen abzuwägen. Wesentliche Fragen, die es vor einer Therapieentscheidung zu beantworten gilt, sind:

  • Ist die Tumorerkrankung für den Patienten in Bezug auf die Lebenserwartung limitierend?

  • Ist die Tumorerkrankung in Bezug auf die Lebensqualität des Patienten limitierend?

  • Verbessert die Therapie die Lebensqualität oder Lebenserwartung?

  • Stehen die Therapie(neben)wirkungen in einem angemessenen Verhältnis zum Therapienutzen?

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 229.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Albertsen PC, Fryback DG et al. (1996) The impact of co-morbidity on life expectancy among men with localized prostate cancer. J Urol 156: 127–132

    Article  PubMed  CAS  Google Scholar 

  • Ausili-Cefaro G, Olmi P (2001) The role of radiotherapy in the management of elderly cancer patients in light of the GROG experience. Critl Rev Oncol Hematol 39: 313–317

    Article  CAS  Google Scholar 

  • Bamias A, Tiliakos I, Karali MD, et al. (2006) Systemic chemotherapy in inoperable or metastatic bladder cancer. Ann Oncol 17(4): 553–561

    Article  PubMed  CAS  Google Scholar 

  • Barry MJ, Albertsen PC, Bagshaw MA et al. (2001) Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostatectomy, external beam radiotherapy, or expectant management: a retrospective analysis. Cancer 91: 2302–2314

    Article  PubMed  CAS  Google Scholar 

  • Boström PJ, Kössi J, Laato M, Nurmi M (2009) Risk factors for mortality and morbidity related to radical cystectomy BJU Int 103: 191–196

    Article  PubMed  Google Scholar 

  • Chang S, Hassan J, Cookson M, Wells N, Smith JJ (2003) Delaying radical cystectomy for muscle-invasive bladder cancer results in worse pathological stage J Urol 170: 1085–1087

    Article  PubMed  Google Scholar 

  • Charlson ME, Pompei P, Ales KL et al. (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40: 373–383

    Article  PubMed  CAS  Google Scholar 

  • Chromecki TF, Mauermann J, Cha EK, Svatek RS, Fajkovic H et al. (2011) Multicenter validation of the prognostic value of patient age in patients treated with radical cystectomy. World J Urol Oct 19 (Epub ahead of print) 2012; 30 (6): 753–759

    Google Scholar 

  • Clark PE, Stein JP, Groshen SG et al. (2005) Radical cystectomy in the elderly: comparison of clinical outcomes between younger and older patients. Cancer 104: 36–43

    Article  PubMed  Google Scholar 

  • Clark PE, Stein JP, Groshen SG et al. (2005) Radical cystectomy in the elderly: comparison of survival between younger and older patients. Cancer 103: 546–552

    Article  PubMed  Google Scholar 

  • Coebergh JW, Janssen-Heijnen ML et al. (1999) Serious co-morbidity among unselected cancer patients newly diagnosed in the southeastern part of the Netherlands in 1993–1996. J Clin Epidemiol 52: 1131–1136

    Article  PubMed  CAS  Google Scholar 

  • de Bono JS, Oudard S, Ozguroglu M, Hansen S, Machiels JP, Kocak I, Gravis G, Bodrogi I, Mackenzie MJ, Shen L, Roessner M, Gupta S, Sartor AO; TROPIC Investigators (2010) Prednisone and cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial. Lancet 376: 1147–54

    Google Scholar 

  • de Bono JS, Logothetis CJ, Molina A, Fizazi K, North S, Chu L, Chi KN, Jones RJ, Goodman OB Jr, Saad F, Staffurth JN, Mainwaring P, Harland S, Flaig TW, Hutson TE, Cheng T, Patterson H, Hainsworth JD, Ryan CJ, Sternberg CN, Ellard SL, Fléchon A, Saleh M, Scholz M, Efstathiou E, Zivi A, Bianchini D, Loriot Y, Chieffo N, Kheoh T, Haqq CM, Scher HI; COU-AA-301 Investigators (2011) Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med 364(21): 1995–2005.

    Google Scholar 

  • Donat SM, Siegrist T, Cronin A, Savage C, Milowsky MI, Herr HW (2010) Radical cystectomy in octogenarians – does morbidity outweigh the potential survival benefits? J Urol 183: 2171–2177

    Article  PubMed  Google Scholar 

  • Droz JP, Balducci L, Bolla M, Emberton M, Fitzpatrick JM, Joniau S, Kattan MW, Monfardini S, Moul JW, Naeim A, van Poppel H, Saad F, Sternberg CN (2010) Management of prostate cancer in older men: Recommendations of a working group of the International Society of Geriatric Oncology. BJU Int 106: 462–9

    Article  PubMed Central  PubMed  Google Scholar 

  • Extermann M (2000) Measuring comorbidity in older cancer patients. Eur J Cancer 36: 453–471

    Article  PubMed  CAS  Google Scholar 

  • Extermann M, Aapro M, Bernabei R, et al. (2005) Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 55(3): 241–52

    Article  PubMed  Google Scholar 

  • Fitzpatrick JM (2008) Management of localized prostate cancer in senior adults: the crucial role of comorbidity. BJU Int 101 (suppl 2): 16–22

    Article  PubMed  Google Scholar 

  • Folstein MF, Folstein SE, Mc Mugh PR (1975) „Mini-Mental State“: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189–198

    Article  PubMed  CAS  Google Scholar 

  • Friedrich C, Kolb G, Wedding U, et al. (2003) Comprehensive geriatric assessment in the elderly cancer patient. Onkologie 26(4): 355–360

    Article  PubMed  CAS  Google Scholar 

  • Froehner M, Brausi MA, Herr HW, Muto G, Studer UE (2009) Complications following radical cystectomy for bladder cancer in the elderly Eur Urol 56: 443–454

    Article  PubMed  Google Scholar 

  • Froehner M, Koch FR, Litz R et al. (2003) Comparison of the American Society of Anesthesiologists Physical Status classification with the Charlson score as predictors of survival after radical prostatectomy. Urology 62: 698–701

    Article  PubMed  Google Scholar 

  • Froehner M, Koch R, Litz R et al. (2004) Which conditions contributing to the Charlson score predict survival after radical prostatectomy? J Urol 171: 697–699

    Article  PubMed  Google Scholar 

  • Greenfield S, Blanco DM et al. (1987) Patterns of care related to age of breast cancer patients. J Am Med Assoc 257: 2766–2770

    Article  CAS  Google Scholar 

  • Guigoz Y, Vellas B and Garry PJ (1994) Mini Nutritional Assessment: A practical assessment tool for grading the nutritional state of elderly patients. Facts and research in gerontology. Supplement 2: 15–59

    Google Scholar 

  • Hamaker ME, Jonker JM, de Rooij SE, Vos AG, Smorenburg CH, van Munster BC (2012) Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review. Lancet Oncol 13 (10): e437–44 [doi: 10.1016/S1470-2045(12)70259-0]

    Google Scholar 

  • Kalbe E, Kessler J, Calabrese P, Smith R, Passmore AP, Brand M, Bullock R (2004) DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriat Psychiat 19: 136–143

    Article  CAS  Google Scholar 

  • Kaplan MH, Feinstein AR (1974) The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis 27: 387–404

    Article  PubMed  CAS  Google Scholar 

  • Kastner C, Armitage J, Kimble A, Rawal J, Carter PG, Venn S (2006) The Charlson comorbidity score: a superior comorbidity assessment tool for the prostate cancer multidisciplinary meeting. Prostate Cancer Prostatic Dis 9 (3): 270–274

    Article  PubMed  CAS  Google Scholar 

  • Kattan MW, Cowen ME et al. (1997) A decision analysis for treatment of clinically localized prostate cancer. J Gen Intern Med 12: 299–305

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Lawton MP, Brody EM (1988) Instrumantal Activities of Daily Living (IADL) Scale – Self-rated version. Psychopharmacol Bull. 24: 789–792

    Google Scholar 

  • Mahoney FI, Barthel DW (1965) Functional evaluation. The Barthel Index. Md State Med J 14/2: 61–65

    Google Scholar 

  • May M, Fritsche HM, Gilfrich C, Brookman-May S, Burger M et al. (2011) Einfluss des Alters auf das karzinomspezifische Überleben nach radikaler Zystektomie Urologe 50: 821–829

    Google Scholar 

  • Mendiola FP, Zorn KC, Gofrit ON (2007) Cystectomy in the ninth decade: operative results and long-term survival outcomes Can J Urol 14: 3628–3634

    PubMed  Google Scholar 

  • Mohile SG, Bylow K, Dale W et al. (2007) A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation. Cancer 109 (4): 802–810

    Article  PubMed  Google Scholar 

  • Newschaffer CJ, Bush TL et al. (1996) Does comorbid disease interact with cancer? An epidemiologic analysis of mortality in a cohort of elderly breast cancer patients. J Gerontol Biol Sci Med Sci 53: 372–378

    Google Scholar 

  • Novotny V, Zastrow S, Koch R, Wirth MP (2011) Radical cystectomy in patients over 70 years of age: impact of comorbidity on perioperative morbidity and mortality W J Urol Nov 2 (Epub ahead of print)

    Google Scholar 

  • Pallis AG, Wedding U, Lacombe D, Soubeyran P, Wildiers H (2010a) Questionnaires and instruments for a multidimensional assessment fo the older cancer patient: what clinicians need to know? Eur J Cancer 2010 46: 1019–25

    Article  CAS  Google Scholar 

  • Pallis AG, Fortpied C, Wedding U, Van Nes MC, Penninckx B, Ring A, Lacombe D, Monfardini S, Scalliet P, Wildiers H (2010b) EORTC elderly task force position paper: approach to the older cancer patient. Eur J Cancer 46: 1502–13

    Article  CAS  Google Scholar 

  • Pallis AG, Ring A, Fortpied C, Penninckx B, Van Nes MC, Wedding U, von Minckwitz G, Johnson CD, Wyld L, Timmer-Bonte A, Bonnetain F, Repetto L, Aarpo M, Luciani A, Wildiers H (2011) EORTC workshop on clinical trial methodology in older individuals with a diagnosis of solid tumors. Ann Oncol 22: 1922–6

    Article  PubMed  CAS  Google Scholar 

  • Podsiadlo D, Richardson S (1991) The timed „Up and Go“: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39: 142–148

    PubMed  CAS  Google Scholar 

  • Shariat SF, Milowsky M, Droller MJ (2009) Bladder cancer in the elderly Urol Oncol 27: 653–667

    Article  PubMed  Google Scholar 

  • Sheikh JI, Yesavage JA (1986) Geriatric Depression Scale (GDS) – Recent evidence and development of a shorter version. Clin Gerontol 5: 165–73

    Article  Google Scholar 

  • Sogni F, Brausi M, Frea B et al (2008) Morbidity and quality of life in elderly patients receiving ileal conduit or orthotopic neobladder after radical cystectomy for invasive bladder cancer Urology 71: 919–923

    Article  PubMed  Google Scholar 

  • Watson IJ, Arfken CL, Birge SJ (1993) Clock completion: An objective screening test for dementia. J Am Geriat Soc 41: 1235–1240

    PubMed  CAS  Google Scholar 

  • Weizer AZ, Joshi D, Daignault S, et al. (2007) Performance status is a predictor of overall survival of elderly patients with muscle invasive bladder cancer. J Urol 177(4): 1287–1293

    Article  PubMed  Google Scholar 

  • Welch HG, Albertsen PC et al. (1996) Assessing competing risks in treating the elderly. Hosp Pract (Off Edn) 31: 155–156, 158–159, 162

    Google Scholar 

  • Wildiers H, Highley MS, de Bruijn EA, van Oosterom AT (2003) Pharmacology of anticancer drugs in the elderly population. Clinical Pharmacokinetics 42: 1213–1242

    Article  PubMed  CAS  Google Scholar 

  • Wolters U, Wolf T, Stutzer H (1996) ASA classifications and perioperative variables as predictors of postoperative outcome. Br J Anesth 77: 217–222

    Article  CAS  Google Scholar 

  • Zebic N, Weinknecht S, Kroepfl D (2005) Radical cystectomy i patients aged≥75 years: an updated review of patients treated with curative and palliative intent BJU Int 95: 1211–1214

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Wedding, U., Krege, S. (2014). Uroonkologie beim älteren Patienten. In: Rübben, H. (eds) Uroonkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-35032-0_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-35032-0_17

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-35031-3

  • Online ISBN: 978-3-642-35032-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics